Table 3.
Attack rate following challenge | Efficacy against wild-type | 50% serum bactericidal | |||||||
---|---|---|---|---|---|---|---|---|---|
Vaccination | with wild-type strain | challenge | titer | ||||||
2457T | J17B | CCH060 | 2457T | J17B | CCH060 | 2457T | J17B | CCH060 | |
CVD 1208S | 0/4 | – | – | 100% | – | – | 1917 | – | – |
CVD 1213 | – | 0/4 | – | – | 100% | – | – | 1356 | – |
CVD 1215 | – | – | 0/4 | – | – | 100% | – | – | 2700 |
Combination | 1/3 | 0/4 | 0/4 | 67% | 100% | 100% | 4395 | 2344 | 742 |